Dermira Inc (NASDAQ:DERM) – Stock analysts at Svb Leerink lifted their Q3 2019 earnings estimates for Dermira in a research report issued to clients and investors on Thursday, August 8th. Svb Leerink analyst P. Sarraf now anticipates that the biopharmaceutical company will earn ($1.48) per share for the quarter, up from their prior estimate of […]
